DE2127078A1 - Vorrichtung zur Behandlung lebender Zellen von Mensch und Tier und deren An Wendung - Google Patents
Vorrichtung zur Behandlung lebender Zellen von Mensch und Tier und deren An WendungInfo
- Publication number
- DE2127078A1 DE2127078A1 DE19712127078 DE2127078A DE2127078A1 DE 2127078 A1 DE2127078 A1 DE 2127078A1 DE 19712127078 DE19712127078 DE 19712127078 DE 2127078 A DE2127078 A DE 2127078A DE 2127078 A1 DE2127078 A1 DE 2127078A1
- Authority
- DE
- Germany
- Prior art keywords
- ring
- dna
- cells
- cell
- chromosomes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000011282 treatment Methods 0.000 title claims description 31
- 241001465754 Metazoa Species 0.000 title claims description 13
- 210000004027 cell Anatomy 0.000 claims description 142
- 230000005291 magnetic effect Effects 0.000 claims description 71
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 29
- 229910052802 copper Inorganic materials 0.000 claims description 27
- 239000010949 copper Substances 0.000 claims description 27
- 230000000694 effects Effects 0.000 claims description 23
- 229910052751 metal Inorganic materials 0.000 claims description 14
- 239000002184 metal Substances 0.000 claims description 14
- 238000001816 cooling Methods 0.000 claims description 13
- 125000004122 cyclic group Chemical group 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 12
- 230000033001 locomotion Effects 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 210000004556 brain Anatomy 0.000 claims description 5
- 230000008878 coupling Effects 0.000 claims description 4
- 238000010168 coupling process Methods 0.000 claims description 4
- 238000005859 coupling reaction Methods 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 3
- 230000004048 modification Effects 0.000 claims description 3
- 230000005284 excitation Effects 0.000 claims description 2
- 230000002829 reductive effect Effects 0.000 claims description 2
- 238000003745 diagnosis Methods 0.000 claims 2
- 230000004913 activation Effects 0.000 claims 1
- 210000004958 brain cell Anatomy 0.000 claims 1
- 230000005684 electric field Effects 0.000 claims 1
- 239000003574 free electron Substances 0.000 claims 1
- 230000001575 pathological effect Effects 0.000 claims 1
- 108020004414 DNA Proteins 0.000 description 98
- 241000700605 Viruses Species 0.000 description 66
- 206010028980 Neoplasm Diseases 0.000 description 36
- 201000011510 cancer Diseases 0.000 description 35
- 210000001766 X chromosome Anatomy 0.000 description 34
- 210000002593 Y chromosome Anatomy 0.000 description 30
- 210000004369 blood Anatomy 0.000 description 28
- 239000008280 blood Substances 0.000 description 28
- 210000002683 foot Anatomy 0.000 description 26
- 210000000481 breast Anatomy 0.000 description 22
- 210000000349 chromosome Anatomy 0.000 description 21
- 210000004940 nucleus Anatomy 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 235000013601 eggs Nutrition 0.000 description 15
- 210000003128 head Anatomy 0.000 description 14
- 102000053602 DNA Human genes 0.000 description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 13
- 125000004429 atom Chemical group 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000002068 genetic effect Effects 0.000 description 9
- 238000004804 winding Methods 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 210000003414 extremity Anatomy 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 7
- 230000005415 magnetization Effects 0.000 description 7
- 210000000653 nervous system Anatomy 0.000 description 7
- 230000036961 partial effect Effects 0.000 description 7
- 238000010276 construction Methods 0.000 description 6
- 241001493065 dsRNA viruses Species 0.000 description 6
- 210000004247 hand Anatomy 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- 208000032839 leukemia Diseases 0.000 description 6
- 102000039446 nucleic acids Human genes 0.000 description 6
- 108020004707 nucleic acids Proteins 0.000 description 6
- 150000007523 nucleic acids Chemical class 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 5
- 239000000306 component Substances 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 241000450599 DNA viruses Species 0.000 description 4
- 239000003990 capacitor Substances 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 230000010355 oscillation Effects 0.000 description 4
- 150000003212 purines Chemical class 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 210000001215 vagina Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 210000000707 wrist Anatomy 0.000 description 4
- 229910001006 Constantan Inorganic materials 0.000 description 3
- 230000005374 Kerr effect Effects 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 3
- 230000001133 acceleration Effects 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 229910052793 cadmium Inorganic materials 0.000 description 3
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 3
- 210000003855 cell nucleus Anatomy 0.000 description 3
- 210000003850 cellular structure Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000005260 human cell Anatomy 0.000 description 3
- 235000020256 human milk Nutrition 0.000 description 3
- 210000004251 human milk Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 201000006417 multiple sclerosis Diseases 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- 230000008447 perception Effects 0.000 description 3
- 210000002826 placenta Anatomy 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 229920002477 rna polymer Polymers 0.000 description 3
- 230000001360 synchronised effect Effects 0.000 description 3
- 210000003371 toe Anatomy 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 206010021718 Induced labour Diseases 0.000 description 2
- 208000007914 Labor Pain Diseases 0.000 description 2
- 208000035945 Labour pain Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000007257 malfunction Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 150000003230 pyrimidines Chemical class 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- FGRBYDKOBBBPOI-UHFFFAOYSA-N 10,10-dioxo-2-[4-(N-phenylanilino)phenyl]thioxanthen-9-one Chemical compound O=C1c2ccccc2S(=O)(=O)c2ccc(cc12)-c1ccc(cc1)N(c1ccccc1)c1ccccc1 FGRBYDKOBBBPOI-UHFFFAOYSA-N 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229920001875 Ebonite Polymers 0.000 description 1
- 244000228957 Ferula foetida Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 240000002129 Malva sylvestris Species 0.000 description 1
- 235000006770 Malva sylvestris Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229910052790 beryllium Inorganic materials 0.000 description 1
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000009109 curative therapy Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000004870 electrical engineering Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000000652 homosexual effect Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 210000000287 oocyte Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000002907 paramagnetic material Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000000191 radiation effect Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 229910052705 radium Inorganic materials 0.000 description 1
- HCWPIIXVSYCSAN-UHFFFAOYSA-N radium atom Chemical compound [Ra] HCWPIIXVSYCSAN-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000021317 sensory perception Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 238000005476 soldering Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 230000004222 uncontrolled growth Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/28—Apparatus for applying thermoelectric currents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4230170A | 1970-06-01 | 1970-06-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2127078A1 true DE2127078A1 (de) | 1971-12-16 |
Family
ID=21921125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19712127078 Pending DE2127078A1 (de) | 1970-06-01 | 1971-06-01 | Vorrichtung zur Behandlung lebender Zellen von Mensch und Tier und deren An Wendung |
Country Status (3)
| Country | Link |
|---|---|
| DE (1) | DE2127078A1 (enExample) |
| FR (1) | FR2097819A5 (enExample) |
| IT (1) | IT944673B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1558338A1 (en) * | 2002-11-04 | 2005-08-03 | Inka Wilhelm | Application device for magnetic field treatment |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2284341A1 (fr) * | 1974-07-10 | 1976-04-09 | Laguerre Rene | Vetements et sous-vetements utilisant les effets peltier et hall pour agir sur divers troubles fonctionnels |
| US5131904A (en) * | 1990-05-04 | 1992-07-21 | Richard Markoll | Treatment of arthritis with magnetic field therapy and apparatus therefor |
-
1971
- 1971-05-31 IT IT5072071A patent/IT944673B/it active
- 1971-06-01 DE DE19712127078 patent/DE2127078A1/de active Pending
- 1971-06-01 FR FR7119821A patent/FR2097819A5/fr not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1558338A1 (en) * | 2002-11-04 | 2005-08-03 | Inka Wilhelm | Application device for magnetic field treatment |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2097819A5 (enExample) | 1972-03-03 |
| IT944673B (it) | 1973-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Morschitzky | Angststörungen | |
| DE60015583T2 (de) | Gerät für therapeutische zwecke zur beeinflussung injezierter magnetischer teilchen mit einem elektromagnetischen wechselgradientenfeld | |
| EP0584715B1 (de) | Verfahren zur Isolierung und Kultivierung von transformierten Zellen sowie Verwendung dieser Zellen zur Herstellung individuumsspezifischer Antikörper | |
| Fox | Cytological estimation of proliferating donor cells during graft-versus-host disease in F1 hybrid mice injected with parental spleen cells | |
| US20160044873A1 (en) | Applications of drift and suspension device | |
| DE60030139T2 (de) | Eine Vorrichtung und eine Methode zur Anregung/Modulation biochemischer Prozesse durch pulsierende ekektromagnetische Felder | |
| DE2127078A1 (de) | Vorrichtung zur Behandlung lebender Zellen von Mensch und Tier und deren An Wendung | |
| Lynch et al. | Subcutaneous phycomycetosis | |
| DE3321238C2 (de) | Verfahren und Vorrichtung zur Fusion von Zellen | |
| Pendleton et al. | The use of norgestomet implants and FSH for estrus synchonization and superovulation in goats | |
| Tischler | Der Grad der Polyploidie bei den Angiospermen in verschiedenen Grossarealen | |
| DUENSING | Zur Pathologie der exteroceptiven Reflexe des Menschen | |
| DE102009049175A1 (de) | Vorrichtung zum Verabreichen von Arzneimitteln und zum Beeinflussen von Arzneimittelwirkungen | |
| Haller | Stress, Cortison und Homöostase: Künstliche Nebennierenrindenhormone und physiologisches Gleichgewicht, 1936-1960 | |
| DE3923848C2 (de) | Das Demaskierungstraining für autologe Immunozyten gegen maskierte Tumorzellen in vitro | |
| Pate | UNICEF Goals in Maternal and Child Health | |
| DE102007010165A1 (de) | Strumpfhose für medizinische Zwecke | |
| Starrs | Home ranch: Ranchers, the federal government, and the partitioning of western North American rangeland. | |
| DE3249946C2 (de) | hTNF-haltiges therapeutisches Mittel gegen maligne Tumoren und dessen Verwendung | |
| Hollender et al. | Analyses et Referates: Physical Therapeutic Methods in Oto-laryngology | |
| DE19745792C1 (de) | Verfahren zum Gewinnen von Proteingemischen und Steuerungsfaktoren aus Wundgranulations-, Epithelisierungs- oder determiniertem Blastozystengewebe | |
| AT268518B (de) | Verfahren zur Herstellung eines lebenden Mumpsvirus | |
| Nasiell | Zur Prothesenlehre des Ohres | |
| Kremer et al. | Colitis ulcerosa | |
| als biographische Ressource | HELMA LUTZ/KATHY DAVIS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OD | Request for examination | ||
| OHN | Withdrawal |